Accleus Receives Regulatory Approval from US FDA for Toro-L Interbody Fusion System
On May 19, 2022, the US Food and Drug Administration (FDA) granted the regulatory approval to Toro-L interbody fusion system developed by Accleus. The device is a biplanar expandable lateral implant designed for a minimal insertion profile and to maximize bone graft delivery through the inserter.
The Toro-L interbody fusion system includes a 14mm-wide insertion profile which further expands to the full width of either 21 or 24mm. During the initial launch of the product, the device be offered with a 10-degree lordotic option and during the full commercial launch, the device will ...
